← Back to Search

CRC Screening Toolkit for Diabetes

N/A

Recruiting

Led By Denalee O'Malley, PhD

Research Sponsored by Rutgers, The State University of New Jersey

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age-eligible for CRC screening (50-74 years of age)

Diagnosis of diabetes mellitus

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial tests a multi-level intervention to improve colon cancer screening for people with diabetes in primary care settings.

Who is the study for?

This trial is for people aged 50-74 with diabetes who are overdue for colorectal cancer (CRC) screening. They must not be up-to-date with CRC tests and can join even if they've started but not finished screening over six months ago. It's not open to those with conditions like past CRC, inflammatory bowel disease, or renal failure.Check my eligibility

What is being tested?

The study is testing a 'Targeted CRC Screening Toolkit' designed to improve the rate of CRC screenings in patients with diabetes within safety-net primary care settings. The approach involves interventions at patient, team, and organizational levels.See study design

What are the potential side effects?

Since this trial focuses on a screening toolkit rather than medication or invasive procedures, there may be minimal side effects related directly to the intervention itself.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 50 and 74 years old.

Select...

I have been diagnosed with diabetes.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Colonoscopy uptake

Up-to-date CRC screening

Secondary outcome measures

Rate of CRC Screening Uptake by Glucose Control (Controlled vs. Uncontrolled) Among Participants with Type 2 Diabetes

Other outcome measures

Implementation Fidelity

Participant Acceptability

Trial Design

1Treatment groups

Experimental Treatment

Group I: Targeted CRC Screening ToolkitExperimental Treatment1 Intervention

Based on national survey data and a community engagement participatory implemention planning group, a tailored combination of widely accepted implementation strategies will be adapted for targeting CRC screening for patients with diabetes. These strategies include but are not limited to: identification of patient and practice-level barriers, patient education, provider reminders, and audit and feedback.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,665 Previous Clinical Trials

40,925,824 Total Patients Enrolled

9 Trials studying Colorectal Cancer Screening

4,681 Patients Enrolled for Colorectal Cancer Screening

Rutgers, The State University of New JerseyLead Sponsor

429 Previous Clinical Trials

64,202 Total Patients Enrolled

Denalee O'Malley, PhDPrincipal InvestigatorRutgers Robert Wood Johnson Medical School; Rutgers Cancer Institute of New Jersey

Media Library

Targeted CRC Screening Toolkit Clinical Trial Eligibility Overview. Trial Name: NCT05785780 — N/A

Colorectal Cancer Screening Research Study Groups: Targeted CRC Screening Toolkit

Colorectal Cancer Screening Clinical Trial 2023: Targeted CRC Screening Toolkit Highlights & Side Effects. Trial Name: NCT05785780 — N/A

Targeted CRC Screening Toolkit 2023 Treatment Timeline for Medical Study. Trial Name: NCT05785780 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical trial accept participants over the age of 40?

"As stated in the criteria for enrollment, patients between 50 and 74 years old are eligible to join this study. Additionally, there are 230 trials available for those below 18 and 1971 studies suitable for senior citizens aged 65 or older."

Answered by AI

Are recruitment efforts underway for this research endeavor?

"The clinicaltrials.gov website confirms that this study is no longer in search of participants, as the last update was on March 24th 2023. However, there are currently 2319 other medical trials which remain open to prospective patients."

Answered by AI

Does my profile meet the criteria for participating in this trial?

"This colorectal cancer research is seeking to recruit 30 participants aged between 50-74. In addition, those being screened for diabetes mellitus who have had a FIT/FOBT test ordered and not completed in the past 6 months or not undergone a sigmoidoscopy/colonoscopy within the previous 12 months are also eligible to join this study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings

Denalee O'Malley 2022. "Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05785780.